Biopolym. Cell. 2004; 20(3):239-243.
Molecular Biomedicine
Search for optimum conditions of mobilization and conservation of the fetal liver cells of human
1Bazika D. A., 1Belyaeva N. V., 2Vasilovskaya S. V., 2Lukash L. L., 3Votyakova I. A., 2Kovalenko O. A., 2Matsuka G. Kh.
  1. Research Center for Radiation Medicine, Academy of Medical Sciences of Ukraine
    street. Melnikova, 53, Kyiv, Ukraine, 04050
  2. Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680
  3. Medical Center of tissue and cell therapy "Embriotech"
    5, Verkhnya Str., Kyiv, Ukraine, 01133


Immunophenotyping the cells of embryonic liver in different conditions of immobilization (washing out the cells, trypsinization or homogenization of the tissue) has shown that the composition of cellular membrane antigens did not show significant difference. As in the case of a morphology study, the cellular samples were presented by the precursor cells, committed into the erythroid direction (50-70 %). The phenotype of those cells was CD34+/low CD117+ CD38+, HLA-DR+/low, CD90+, CD7+/low, CD45RO+/low, CD36+++, CD71+++, CD33+, CD13+ , CD14+/low CD61+/Iow. Comparative analysis has shown that the portion of a «pure» CD34+ population was the largest in the samples of cellular suspensions where the cells were isolated by trypsinization of embryonic tissue and kept in cryoconservation conditions during 3 weeks and the smallest one in the samples of cellular suspensions, obtained by homogenization of the tissue.


[1] Zandstra PW, Le HV, Daley GQ, Griffith LG, Lauffenburger DA. Leukemia inhibitory factor (LIF) concentration modulates embryonic stem cell self-renewal and differentiation independently of proliferation. Biotechnol Bioeng. 2000;69(6):607-17.
[2] Campagnoli C, Fisk N, Overton T, Bennett P, Watts T, Roberts I. Circulating hematopoietic progenitor cells in first trimester fetal blood. Blood. 2000;95(6):1967-72.
[3] Gratama JW, Menendez P, Kraan J, Orfao A. Loss of CD34(+) hematopoietic progenitor cells due to washing can be reduced by the use of fixative-free erythrocyte lysing reagents. J Immunol Methods. 2000;239(1-2):13-23.
[4] Sukhikh GT. Transplantation of fetal cells in medicine: present and future. Bull Exp Biol Med. 1998; 126, App. 1:3-13.
[5] Lukash L. L., Vasilovskaya S. V. Mammalian stem cells in vitro as a basis for the development of new biotechnologies. Biopolym. Cell. 2001; 17(3):203-211
[6] Chernenko VIu, Lukash LL, Matsevich LL, Kochubei TP, Elesichev AA, Klimenko EA, Gorban' LN. Using method of DNA microelectrophoresis for the assessment of genotoxic effects of mutagens in cultured human hemopoietic cells. Tsitol Genet. 2004;38(1):31-5.
[7] Chertkov YaL, Drize YaYa. How is the maintenance of the hematopoietic system. Gematol Transfuziol. 1998; 3:3-8.
[8] Bazyka DA, Belyayeva YaV, Bebeiiko VG. CD34+-predecessors in cryopreserved human fetal liver tissue. Ukrainian journal of hematology and transfusiology. 2001; 3(1):30-35.
[9] Vasylovska S. V., Votyakova I. A., Lukash L. L., Matsuka G. H. Obtaining and characteristics of human cells at early haemopoiesis stages when cultured in vitro. Biopolym. Cell. 2002; 18(6):534-539
[10] New methods of animal tissue culture. Moscow, Mir, 1976; 255 p.
[11] MacPherson I., Montagnier L. Agar suspension culture for the selective assay of cells transformed by polyoma virus. Virology. 1964;23:291-4.
[12] Lukash L. L., Podolskaya S. V., Suhorada H. M., Kostetskaya K. V., Kostetsky I. E., Varzanova I. S., Patskovsky Yu. V., Vavilina I. V., Deis S. V. The influence of alkylating agent MNNG on mutagenic effect of exogeneous recombinant DNA. Biopolym. Cell. 1995; 11(1):87-91
[13] Torubarova YaA, Kopyl'iyeva YeA, Studenikin VM. Hematopoietic fetal liver cells: immunophenotypic characterization. Gematol Transfuziol. 1998; 3:49-57.
[14] Gluzman DF, Avramenko YaV, Sklyarenko DM, Nagornaya VA. Cellular basis of hematopoietic and immune system. Lab. diagnosis of cancer. Kiev, MORION, 1998:5-89.
[15] Golfier F, Barcena A, Cruz J, Harrison M, Muench M. Mid-trimester fetal livers are a rich source of CD34+/++ cells for transplantation. Bone Marrow Transplant. 1999;24(5):451-61.